Clinical Trial Update: Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with temozolomide with or without irinotecan for pediatric neuroblastoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Irinotecan (Irinotecan)
• Temozolomide (Temozolomide)

Snippet

Sponsor: University of Birmingham | Conditions: Neuroblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING